Cystatin C and uncontrolled hypertension.


Journal

Anatolian journal of cardiology
ISSN: 2149-2271
Titre abrégé: Anatol J Cardiol
Pays: Turkey
ID NLM: 101652981

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 30 10 2020
pubmed: 31 10 2020
medline: 7 8 2021
Statut: ppublish

Résumé

Increased serum level of cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. We investigated the predictive value of serum cystatin C for controlling hypertension in an observational study. We screened 1037 adults residing in both rural and urban communities. They were grouped based on their diagnosis and control of hypertension. Serum cystatin C levels in patients with uncontrolled hypertension were higher than those in patients with controlled hypertension (0.98±0.23 mg/L vs. 0.89±0.19 mg/L, p=0.001). However, serum creatinine levels were similar between these groups (0.72±0.20 mg/dL vs. 0.70±0.18 mg/dL, p=0.89). Serum cystatin C levels increased the probability of uncontrolled hypertension independent from confounding factors (odds ratio, 1.48; 95% confidence interval, 1.09-5.64; p=0.03). Subtle kidney dysfunction may be detected using serum cystatin C concentrations among patients with poor blood pressure control and normal serum creatinine levels.

Identifiants

pubmed: 33122483
doi: 10.14744/AnatolJCardiol.2020.78974
pmc: PMC7724385
doi:

Substances chimiques

Biomarkers 0
Cystatin C 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-315

Références

Hypertension. 2014 Sep;64(3):501-7
pubmed: 24958503
Hypertension. 2005 Jun;45(6):1119-24
pubmed: 15851626
Blood Press. 2015 Apr;24(2):79-85
pubmed: 25541646
Circulation. 2012 Oct 23;126(17):2105-14
pubmed: 23091084
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
Clin Biochem. 2007 Mar;40(5-6):383-91
pubmed: 17316593
N Engl J Med. 2012 Jul 5;367(1):20-9
pubmed: 22762315
Lancet. 2013 Jul 13;382(9887):158-69
pubmed: 23727165
Ren Fail. 2005;27(3):247-53
pubmed: 15957539
Am J Hypertens. 2014 Apr;27(4):596-602
pubmed: 24008123
Am Heart J. 2008 Jan;155(1):82-6
pubmed: 18082494
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
BMJ. 2008 May 17;336(7653):1121-3
pubmed: 18480116
Ann Clin Biochem. 2003 Nov;40(Pt 6):648-55
pubmed: 14629803
JAMA. 2010 May 26;303(20):2043-50
pubmed: 20501926
Am J Hypertens. 2006 Sep;19(9):939-46
pubmed: 16942937
Eur Heart J. 2009 Feb;30(3):314-20
pubmed: 19153178
Circulation. 2011 Aug 30;124(9):1046-58
pubmed: 21824920
Ann Intern Med. 2005 Mar 1;142(5):342-51
pubmed: 15738453
Kidney Int. 2007 Aug;72(3):247-59
pubmed: 17568785
J Am Soc Hypertens. 2011 Sep-Oct;5(5):378-84
pubmed: 21498146
Nat Rev Nephrol. 2012 Oct;8(10):602-9
pubmed: 22926246
Am J Kidney Dis. 2000 Jul;36(1):29-34
pubmed: 10873868
Atherosclerosis. 2010 Mar;209(1):300-5
pubmed: 19819453
N Engl J Med. 2013 Sep 5;369(10):932-43
pubmed: 24004120
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715
Ann Intern Med. 2008 Apr 1;148(7):501-8
pubmed: 18378946

Auteurs

Mehmet Onur Omaygenç (MO)

Department of Cardiology, Faculty of Medicine, İstanbul Medipol University; İstanbul-Turkey.

Özgür Ulaş Özcan (ÖU)

Department of Cardiology, Faculty of Medicine, İstanbul Medipol University; İstanbul-Turkey.

Beytullah Çakal (B)

Department of Cardiology, Faculty of Medicine, İstanbul Medipol University; İstanbul-Turkey.

Oğuz Karaca (O)

Department of Cardiology, Faculty of Medicine, İstanbul Medipol University; İstanbul-Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH